The purpose of this research is to see if an experimental vaccine, which is created from your tumor tissue and dendritic cells isolated from your blood, can be an effective therapy when given after your standard treatment of surgery, chemotherapy, and radiation.
Thank you for your interest, but this study will start enrolling soon.
United States (Nationwide)
Soma Sengupta
LCCC - Clinical Trials
Clinical or Medical
Interventional
Cancer (Brain and Other Nervous System)
25-0536
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
